The GOLD Report provides and un-biased overview and interpretation of the evidence on all aspects of the management of patients with COPD, including:
- • Diagnosis and assessment
- • Initial pharmacological and non-pharmacological management
- • Follow-up pharmacological and non-pharmacological management
- • Management of exacerbations
- • Management of comorbidities
In many parts of the world COPD services are rudimentary and many therapies, both pharmacological and non-pharmacological, are not available. We hope providers will use the recommendations in the Report as the basis for commissioning services, identifying gaps in service provision and assessing the quality of COPD services.
This page provides links to background material produced by members of the GOLD Board of Directors and Science Committee which discuss issues that providers may also wish to consider, including:
- • Burden of disease
- • Ways of addressing disparities in outcomes
- • Components of good quality COPD services and metrics for their assessment
Halpin DMG, Celli BR, Criner GJ, Frith P, López Varela MV, Salvi S, Vogelmeier CF, Chen R, Mortimer K, Montes de Oca M, Aisanov Z, Obaseki D, Decker R, Agusti A. It is time for the world to take COPD seriously: a statement from the GOLD board of directors. Eur Respir J. 2019;54:1900914.
Martinez FJ, Agusti A, Celli BR, Han MK, Allinson J, Bhatt SP, Calverley P, Chotirmall SH, Chowdhury B, Darken P, Da Silva CA, Donaldson G, Dorinsky P, Dransfield M, Faner R, Halpin DM, Jones P, Krishnan JA, Locantore N, Martinez FD, Mullerova H, Price D, Rabe KF, Reisner C, Singh D, Vestbo J, Vogelmeier CF, Wise RA, Tal-Singer R, Wedzicha JA. Treatment Trials in Pre-COPD and Young COPD: Time to Move Forward. Am J Respir Crit Care Med 2021 Oct 21. doi: 10.1164/rccm.202107-1663SO.
Han MK, Agusti A, Celli B, Criner GJ, Halpin DMG, Roche N, Papi A, Stockley R, Wedzicha JW, Vogelmeier CF. From Gold 0 to Pre-COPD. Am J Respir Crit Care Med. 2021;203:414-423.
Mortimer K, Montes de Oca M, Salvi S, Balakrishnan K, Hadifled R, Ramirez A; Halpin DMG, Ozoh OB, Han M, Perez Padilla R; Kirenga BJ, Balmes J. Household air pollution and COPD: cause and effect or confounding by other aspects of poverty? Int J Tuberc Lung Dis 2022 (accepted for publication)
To T, Viegi G, Cruz A, Taborda-Barata L, Asher M, Behera D, Bennoor K, Boulet L-P, Bousquet J, Camargos P Conceicao, C Gonzalez Diaz S, El-Sony A, Erhola M, Gaga M, Halpin D, Harding L, Maghlakelidze T, Masjedi M, Mohammad Y, Nunes E, Pigearias B, Sooronbaev T, Stelmach R, Tsiligianni I, LE L, Valiulis A, Wang Chen, Williams S, Yorgancioglu A. A Global Respiratory Perspective on the COVID-19 Pandemic: Commentary and Action Proposals. Eur Respir J. 2020;56:2001704.
Meghji J, Mortimer K, Agusti A, Allwood BW, Asher I, Bateman ED, Bissell K, Bolton CE, Bush A, Celli B, Chiang CY, Cruz AA, Dinh-Xuan AT, El Sony A, Fong KM, Fujiwara PI, Gaga M, Garcia-Marcos L, Halpin DMG, Hurst JR, Jayasooriya S, Kumar A, Lopez-Varela MV, Masekela R, Mbatchou Ngahane BH, Montes de Oca M, Pearce N, Reddel HK, Salvi S, Singh SJ, Varghese C, Vogelmeier CF, Walker P, Zar HJ, Marks GB. Improving lung health in low-income and middle-income countries: from challenges to solutions. Lancet. 2021 Mar 6;397(10277):928-940.
Forum of International Respiratory Societies. The global impact of respiratory disease. Third Edition. European Respiratory Society, 2021 https://www.firsnet.org/resources/publications